Description: Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.
Home Page: www.eyenovia.com
EYEN Technical Analysis
295 Madison Avenue
New York,
NY
10017
United States
Phone:
917 289 1117
Officers
| Name | Title |
|---|---|
| Dr. Tsontcho Ianchulev M.D., M.P.H., MPH | Co-Founder, Pres, Chief Medical Officer & Non-Exec. Chairman |
| Mr. Michael M. Rowe | CEO & Director |
| Mr. John P. Gandolfo CPA | CFO & Sec. |
| Mr. Bren Kern | Sr. VP of Manufacturing & Operations |
| Alexander Lobo | Investor Contact |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.228 |
| Price-to-Sales TTM: | 6.4156 |
| IPO Date: | 2018-01-25 |
| Fiscal Year End: | December |
| Full Time Employees: | 43 |